Metabolic mechanisms of naphthalene toxicity in lung

萘肺毒性的代谢机制

基本信息

  • 批准号:
    8814765
  • 负责人:
  • 金额:
    $ 42.77万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-08-20 至 2018-04-30
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Naphthalene (NA) is an acute respiratory toxicant and a potential human lung carcinogen. Human exposure to NA is widespread, but human susceptibility to NA toxicity is poorly understood. The verdict on human susceptibility to NA toxicity will have a significant impact on public health, could save many lives, but involves economic costs. The overall theme of this ViCTER program is to study mechanisms of lung toxicity, including tolerance, induced by NA, in order to improve assessment of human lung cancer risks from NA and other related toxicants. Three Aims are proposed, 1) to define whether NA is a genotoxic carcinogen through a direct mechanism; 2) to test the role of inflammatory cell estrogen production in NA-induced lung toxicity and tolerance; and 3) to identify cellular stress response for NA-induced lung toxicity and tolerance. These Aims significantly expand the scope of the current project by studying molecular and cellular events downstream of the initial bio-activation step, while the parent grant is focused on the NA bio-activation step. The consortium allows extensive collaborations among the participants, in sharing of animal models, unique skills (e.g., airway dissection), instruments, and molecular, cellular, and genotoxic perspectives. Data from the Aims will provide complementary views of the complex, multi-step process of NA-induced tissue damage and repair that lead to preneoplastic changes and eventual carcinogenesis. Aim 1 will provide much needed data on whether NA induces stable DNA adducts in the lung in vivo, and will translate our studies to a more human-like model system. The results would drive risk estimation, guide future mechanistic studies, and provide methodology and approaches for testing other carcinogens. Aim 2 will produce a novel knockout mouse model and establish role of macrophage-derived estrogen in NA-induced hyper proliferative response and tolerance, which precedes development of hyperplastic/dysplastic nodules. Aim 3 will identify the specific reactive oxygen species damage driving acute lung toxicity and signaling pathways that allow for NA-induced tolerance. The results would provide insight for potential mitigating agents and biomarkers for future translational studies to identify and protect at-risk individuals.
 描述(由申请人证明):nachthalene(NA)是一种急性呼吸有毒物质和潜在的人类肺癌。公共卫生,但涉及肺部毒品的经济成本。 NA诱导的肺毒和耐受性的炎症细胞雌激素的产生;生物激活步骤允许参与者之间的合作,共享动物模型,独特的技能(例如气道解剖),分子,细胞和基因毒性的观点。 Topread的肿瘤变化和最终的致癌作用将产生一种新型的小鼠模型,并在NA诱导的超声音和耐受性中建立巨噬细胞的作用,这是在增生结节的发展之前。 ND生物标志物用于未来的翻译研究,以识别和保护处于危险的人。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Xinxin Ding其他文献

Xinxin Ding的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Xinxin Ding', 18)}}的其他基金

Human CYP2A and respiratory tract xenobiotic toxicity
人类 CYP2A 和呼吸道外源性毒性
  • 批准号:
    8869326
  • 财政年份:
    2014
  • 资助金额:
    $ 42.77万
  • 项目类别:
Human CYP2A and respiratory tract xenobiotic toxicity
人类 CYP2A 和呼吸道外源性毒性
  • 批准号:
    8874543
  • 财政年份:
    2014
  • 资助金额:
    $ 42.77万
  • 项目类别:
Metabolic mechanisms of naphthalene toxicity in lung
萘肺毒性的代谢机制
  • 批准号:
    8840377
  • 财政年份:
    2013
  • 资助金额:
    $ 42.77万
  • 项目类别:
Metabolic Mechanisms of Naphthalene Toxicity in Lung
萘毒性肺代谢机制
  • 批准号:
    9765706
  • 财政年份:
    2013
  • 资助金额:
    $ 42.77万
  • 项目类别:
Metabolic Mechanisms of Naphthalene Toxicity in Lung
萘毒性肺代谢机制
  • 批准号:
    9921370
  • 财政年份:
    2013
  • 资助金额:
    $ 42.77万
  • 项目类别:
Metabolic mechanisms of naphthalene toxicity in lung
萘肺毒性的代谢机制
  • 批准号:
    9352924
  • 财政年份:
    2013
  • 资助金额:
    $ 42.77万
  • 项目类别:
Metabolic mechanisms of naphthalene toxicity in lung
萘肺毒性的代谢机制
  • 批准号:
    8852124
  • 财政年份:
    2013
  • 资助金额:
    $ 42.77万
  • 项目类别:
Metabolic Mechanisms of Naphthalene Toxicity in Lung
萘毒性肺代谢机制
  • 批准号:
    10403995
  • 财政年份:
    2013
  • 资助金额:
    $ 42.77万
  • 项目类别:
Metabolic mechanisms of naphthalene toxicity in lung
萘肺毒性的代谢机制
  • 批准号:
    8589793
  • 财政年份:
    2013
  • 资助金额:
    $ 42.77万
  • 项目类别:
Metabolic Mechanisms of Naphthalene Toxicity in Lung
萘毒性肺代谢机制
  • 批准号:
    10612426
  • 财政年份:
    2013
  • 资助金额:
    $ 42.77万
  • 项目类别:

相似国自然基金

ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
  • 批准号:
    82370084
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
急性肺损伤中Hippo通路调控肺泡中间过渡态上皮细胞再生分化机制研究
  • 批准号:
    82372185
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
土家药山姜通过调控中性粒细胞胞外捕获网的急性肺损伤保护作用及机制研究
  • 批准号:
    82360846
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
基于“肠肺轴”探讨迷迭香酸通过调控肠道菌群对LPS致急性肺损伤小鼠的保护作用及其机制
  • 批准号:
    32360897
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
肺泡巨噬细胞外泌体miR-122-5p调控肺泡II型上皮细胞自噬在脓毒症急性肺损伤中的作用及机制
  • 批准号:
    82360024
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Cell-free hemoglobin-oxidized LDL-LOX-1 axis and microvascular hyperpermeability during sepsis
脓毒症期间无细胞血红蛋白氧化的 LDL-LOX-1 轴和微血管通透性过高
  • 批准号:
    10739620
  • 财政年份:
    2023
  • 资助金额:
    $ 42.77万
  • 项目类别:
The Role of Lipids in Obesity-mediated Protection in Sepsis
脂质在肥胖介导的脓毒症保护中的作用
  • 批准号:
    10729051
  • 财政年份:
    2023
  • 资助金额:
    $ 42.77万
  • 项目类别:
Extending CPAP Therapy in Stable Preterm Infants to Increase Lung Growth and Function: A Randomized Controlled Trial
延长稳定早产儿的 CPAP 治疗以促进肺部生长和功能:一项随机对照试验
  • 批准号:
    10026341
  • 财政年份:
    2020
  • 资助金额:
    $ 42.77万
  • 项目类别:
Extending CPAP Therapy in Stable Preterm Infants to Increase Lung Growth and Function: A Randomized Controlled Trial
延长稳定早产儿的 CPAP 治疗以促进肺部生长和功能:一项随机对照试验
  • 批准号:
    10480783
  • 财政年份:
    2020
  • 资助金额:
    $ 42.77万
  • 项目类别:
Extending CPAP Therapy in Stable Preterm Infants to Increase Lung Growth and Function: A Randomized Controlled Trial
延长稳定早产儿的 CPAP 治疗以促进肺部生长和功能:一项随机对照试验
  • 批准号:
    10268177
  • 财政年份:
    2020
  • 资助金额:
    $ 42.77万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了